DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Winterhoff BJN, Kommoss S, Oberg AL et al.
Bevacizumab and improvement of progression-free survival (PFS) for patients with the mesenchymal molecular subtype of ovarian cancer.
J Clin Oncol 2014;
32 (5) (suppl; abstr 5509)
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.